Literature DB >> 26137952

Hypertension, Dietary Sodium, and Cognitive Decline: Results From the Women's Health Initiative Memory Study.

Bernhard Haring1, Chunyuan Wu2, Laura H Coker3, Arjun Seth4, Linda Snetselaar5, JoAnn E Manson6, Jacques E Rossouw7, Sylvia Wassertheil-Smoller4.   

Abstract

BACKGROUND: To investigate the relationships of hypertension, antihypertensive treatment, and sodium intake on cognitive decline in older women.
METHODS: Prospective follow-up of 6,426 cognitively intact women aged 65-79 years enrolled in the Women's Health Initiative Memory Study (WHIMS) with a median follow-up of 9.1 years. Dietary sodium intake was determined by food frequency questionnaires. Hypertension was defined as self-report of current drug therapy for hypertension. Blood pressure (BP) control was assessed by treatment for hypertension and clinic measurement of systolic BP ≥ 140 mm Hg or diastolic BP ≥ 90 mm Hg at baseline. Cognitive functioning was assessed annually by global cognitive screening, neurocognitive, and neuropsychiatric evaluations. Cognitive decline was identified by the incidence of mild cognitive impairment (MCI) or probable dementia (PD). Cox proportional hazards analyses were used to calculate hazard ratios (HRs).
RESULTS: Hypertension was associated with an increased risk for cognitive decline (HR 1.20; 95% confidence interval (CI) 1.04, 1.39; P = 0.02). Among women with antihypertensive medication, those with BP ≥140/90 mm Hg (uncontrolled BP) were at highest risk for developing cognitive decline (HR 1.30; 95% CI 1.05, 1.60) compared to women without treatment and BP <140/90mm Hg (controlled BP). Sodium intake >1,500 mg/day did not alter the risk for cognitive decline in hypertensive women or women with antihypertensive treatment (P for interaction = 0.96 or 0.97).
CONCLUSIONS: Women with antihypertensive treatment and uncontrolled BP showed highest risk estimates for developing cognitive decline compared to non-hypertensive women. Sodium intake did not modify the risk for cognitive decline in women with hypertension or receiving antihypertensive medication. CLINICAL TRIAL REGISTRATION: http://www.clinicaltrials.gov. Unique identifier: NCT00685009 and NCT00745056. © American Journal of Hypertension, Ltd 2015. All rights reserved. For Permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  antihypertensive treatment; blood pressure; cognitive decline; dietary sodium; hypertension.

Mesh:

Substances:

Year:  2015        PMID: 26137952      PMCID: PMC4723668          DOI: 10.1093/ajh/hpv081

Source DB:  PubMed          Journal:  Am J Hypertens        ISSN: 0895-7061            Impact factor:   2.689


  37 in total

1.  The importance of population-wide sodium reduction as a means to prevent cardiovascular disease and stroke: a call to action from the American Heart Association.

Authors:  Lawrence J Appel; Edward D Frohlich; John E Hall; Thomas A Pearson; Ralph L Sacco; Douglas R Seals; Frank M Sacks; Sidney C Smith; Dorothea K Vafiadis; Linda V Van Horn
Journal:  Circulation       Date:  2011-01-13       Impact factor: 29.690

2.  Association between cardiovascular outcomes and antihypertensive drug treatment in older women.

Authors:  Sylvia Wassertheil-Smoller; Bruce Psaty; Philip Greenland; Albert Oberman; Theodore Kotchen; Charles Mouton; Henry Black; Aaron Aragaki; Maurizio Trevisan
Journal:  JAMA       Date:  2004-12-15       Impact factor: 56.272

3.  Sodium, blood pressure, and cardiovascular disease: further evidence supporting the American Heart Association sodium reduction recommendations.

Authors:  Paul K Whelton; Lawrence J Appel; Ralph L Sacco; Cheryl A M Anderson; Elliott M Antman; Norman Campbell; Sandra B Dunbar; Edward D Frohlich; John E Hall; Mariell Jessup; Darwin R Labarthe; Graham A MacGregor; Frank M Sacks; Jeremiah Stamler; Dorothea K Vafiadis; Linda V Van Horn
Journal:  Circulation       Date:  2012-11-02       Impact factor: 29.690

Review 4.  Methodological issues in cohort studies that relate sodium intake to cardiovascular disease outcomes: a science advisory from the American Heart Association.

Authors:  Laura K Cobb; Cheryl A M Anderson; Paul Elliott; Frank B Hu; Kiang Liu; James D Neaton; Paul K Whelton; Mark Woodward; Lawrence J Appel
Journal:  Circulation       Date:  2014-02-10       Impact factor: 29.690

5.  Urinary sodium and potassium excretion, mortality, and cardiovascular events.

Authors:  Martin O'Donnell; Andrew Mente; Sumathy Rangarajan; Matthew J McQueen; Xingyu Wang; Lisheng Liu; Hou Yan; Shun Fu Lee; Prem Mony; Anitha Devanath; Annika Rosengren; Patricio Lopez-Jaramillo; Rafael Diaz; Alvaro Avezum; Fernando Lanas; Khalid Yusoff; Romaina Iqbal; Rafal Ilow; Noushin Mohammadifard; Sadi Gulec; Afzal Hussein Yusufali; Lanthe Kruger; Rita Yusuf; Jephat Chifamba; Conrad Kabali; Gilles Dagenais; Scott A Lear; Koon Teo; Salim Yusuf
Journal:  N Engl J Med       Date:  2014-08-14       Impact factor: 91.245

6.  Design of the Women's Health Initiative clinical trial and observational study. The Women's Health Initiative Study Group.

Authors: 
Journal:  Control Clin Trials       Date:  1998-02

7.  Reducing the risk of dementia: efficacy of long-term treatment of hypertension.

Authors:  Rita Peila; Lon R White; Kamal Masaki; Helen Petrovitch; Lenore J Launer
Journal:  Stroke       Date:  2006-04-06       Impact factor: 7.914

8.  Effect of estrogen plus progestin on global cognitive function in postmenopausal women: the Women's Health Initiative Memory Study: a randomized controlled trial.

Authors:  Stephen R Rapp; Mark A Espeland; Sally A Shumaker; Victor W Henderson; Robert L Brunner; JoAnn E Manson; Margery L S Gass; Marcia L Stefanick; Dorothy S Lane; Jennifer Hays; Karen C Johnson; Laura H Coker; Maggie Dailey; Deborah Bowen
Journal:  JAMA       Date:  2003-05-28       Impact factor: 56.272

9.  The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part I. Clinical and neuropsychological assessment of Alzheimer's disease.

Authors:  J C Morris; A Heyman; R C Mohs; J P Hughes; G van Belle; G Fillenbaum; E D Mellits; C Clark
Journal:  Neurology       Date:  1989-09       Impact factor: 9.910

10.  Conjugated equine estrogens and incidence of probable dementia and mild cognitive impairment in postmenopausal women: Women's Health Initiative Memory Study.

Authors:  Sally A Shumaker; Claudine Legault; Lewis Kuller; Stephen R Rapp; Leon Thal; Dorothy S Lane; Howard Fillit; Marcia L Stefanick; Susan L Hendrix; Cora E Lewis; Kamal Masaki; Laura H Coker
Journal:  JAMA       Date:  2004-06-23       Impact factor: 56.272

View more
  23 in total

1.  Locus Coeruleus Degeneration Induces Forebrain Vascular Pathology in a Transgenic Rat Model of Alzheimer's Disease.

Authors:  Sarah C Kelly; Erin C McKay; John S Beck; Timothy J Collier; Anne M Dorrance; Scott E Counts
Journal:  J Alzheimers Dis       Date:  2019       Impact factor: 4.472

2.  Association between Dietary Sodium Intake and Cognitive Function in Older Adults.

Authors:  T M Rush; D Kritz-Silverstein; G A Laughlin; T T Fung; E Barrett-Connor; L K McEvoy
Journal:  J Nutr Health Aging       Date:  2017       Impact factor: 4.075

3.  Hypertension and cognitive impairment.

Authors:  Wilbert S Aronow
Journal:  Ann Transl Med       Date:  2017-06

4.  Dietary Sodium Intake and Health Indicators: A Systematic Review of Published Literature between January 2015 and December 2019.

Authors:  Katherine J Overwyk; Zerleen S Quader; Joyce Maalouf; Marlana Bates; Jacqui Webster; Mary G George; Robert K Merritt; Mary E Cogswell
Journal:  Adv Nutr       Date:  2020-09-01       Impact factor: 8.701

5.  Dietary Sodium/Potassium Intake Does Not Affect Cognitive Function or Brain Imaging Indices.

Authors:  Kristen L Nowak; Linda Fried; Anna Jovanovich; Joachim Ix; Kristine Yaffe; Zhiying You; Michel Chonchol
Journal:  Am J Nephrol       Date:  2018-01-24       Impact factor: 3.754

Review 6.  Hypertension and aging.

Authors:  Thomas W Buford
Journal:  Ageing Res Rev       Date:  2016-02-01       Impact factor: 10.895

7.  Hypertension and obesity moderate the relationship between β-amyloid and cognitive decline in midlife.

Authors:  Lindsay R Clark; Rebecca L Koscik; Samantha L Allison; Sara E Berman; Derek Norton; Cynthia M Carlsson; Tobey J Betthauser; Barbara B Bendlin; Bradley T Christian; Nathaniel A Chin; Sanjay Asthana; Sterling C Johnson
Journal:  Alzheimers Dement       Date:  2018-10-25       Impact factor: 21.566

Review 8.  High blood pressure in dementia: How low can we go?

Authors:  Yuda Turana; Jeslyn Tengkawan; Yook-Chin Chia; Boon Wee Teo; Jinho Shin; Guru Prasad Sogunuru; Arieska Ann Soenarta; Huynh Van Minh; Peera Buranakitjaroen; Chen-Huan Chen; Jennifer Nailes; Satoshi Hoshide; Sungha Park; Saulat Siddique; Jorge Sison; Apichard Sukonthasarn; Jam Chin Tay; Tzung-Dau Wang; Narsingh Verma; Yu-Qing Zhang; Ji-Guang Wang; Kazuomi Kario
Journal:  J Clin Hypertens (Greenwich)       Date:  2019-12-09       Impact factor: 3.738

Review 9.  More evidence that salt increases blood pressure and risk of kidney disease from the Science of Salt: A regularly updated systematic review of salt and health outcomes (April-July 2016).

Authors:  JoAnne Arcand; Michelle M Y Wong; Joseph Alvin Santos; Alexander A Leung; Kathy Trieu; Sudhir Raj Thout; Jacqui Webster; Norm R C Campbell
Journal:  J Clin Hypertens (Greenwich)       Date:  2017-08       Impact factor: 3.738

10.  Independent and Differential Effects of Obesity and Hypertension on Cognitive and Functional Abilities.

Authors:  Robert P Fellows; Maureen Schmitter-Edgecombe
Journal:  Arch Clin Neuropsychol       Date:  2018-02-01       Impact factor: 2.813

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.